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Abstract 
Objective: This study aimed to evaluate the phenotypic and genotypic characterization of biofilm formation and spa 
and ica genes among clinical isolates of methicillin-resistant Staphylococcus aureus.
Result: This cross-sectional study was performed on 146 Staphylococcus aureus isolates from hospitalized patients in 
Isfahan Province Hospitals. MRSA isolates were confirmed using disk diffusion test with oxacillin disk and amplification 
of mecA gene by PCR assays. Ability of biofilm production was evaluated targeting the icaA and icaD genes. Of 146 
Staphylococcus aureus isolates, 24 (16.4%) carried mecA genes and identified as MRSA strains. Strong ability of biofilm 
production was seen among 76.02% (111/146) S. aureus isolates and 87.5% (21/24) MRSA strains, respectively. Also, 
75.0% (18/24) MRSA isolates carried icaA and icaD was not detected in these strains. Analysis of spa gene showed 
70.83% (17/24) MRSA strains were spa positive. From which 14 and 3 strains identified with one band (150, 270, 300, 
360, 400 bp) and two bands (150–300 bp), respectively. According to data obtained, the prevalence of MRSA isolates 
from Isfahan Province Hospitals is relatively high and a remarkable percentage of them show strong power in biofilm 
production. Also analysis of spa gene showed a fairly large diversity among MRSA strains.
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Introduction
Staphylococcus aureus (S. aureus) is one of the most 
common causes of hospital- and community-acquired 
infections [1–3]. The development of hospital–adapted 
MRSA clones in the world, has really been problematic 
[4, 5]. Resistance to methicillin in S. aureus strains is due 
to acquisition of mecA gene which encodes a changed 
penicillin-binding protein (PBP2a) [6–8].
Although mecA gene alone cannot be indicative of 
resistance to methicillin and existence of another ancil-
lary gene especially femA (factors essential for methi-
cillin-resistance) is also necessary for development of 
methicillin resistance [9]. The S. aureus protein A (SpA), 
as important virulence factor, is encoded by spa gene, 
which contain variable polymorphic X region [10]. The 
molecular characterization of X region of spa gene is 
documented as an exact method for typing of S. aureus 
strains [11].
The importance of biofilm production in pathogen-
esis of S. aureus and development of MDR strains has 
been documented [12, 13]. Apart from other adhesion 
factors, a polysaccharide intercellular adhesion (PIA) 
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which is encoded by ica operon is essential for bio-
film formation in staphylococci [13, 14]. The intercel-
lular adhesion (ica) locus consists of icaADBC operon 
which contains four genes encoding the main proteins 
required for the generation of PIA. The first two genes 
including icaA and icaD perform principal role in the 
synthesis of exopolysaccharides [14]. The product of 
icaA gene is a transmembrane protein with N-acetyl-
glucosaminyl transferases enzymatic activity which led 
to synthesis of the poly-N acetyl glucosamine polymer 
[15]. It has been documented that, the product of the 
icaD gene, is essential for the most favorable enzy-
matic activity of the product of icaA gene [15, 16].
In this study methicillin-resistant Staphylococcus 
aureus strains were identified targeting mecA and 
femA genes and the analysis of spa gene among MRSA 
strains was done. Also the ability of biofilm formation 
was evaluated using genes carried by ica locus.
Main text
Materials and methods
Bacterial isolates
In this cross-sectional study, 146 S. aureus isolates 
were collected during June 2017 to September 2018 
from hospitalized patients in Isfahan Province Hospi-
tals. Identification of isolates as S. aureus strains was 
done by standard microbiological methods [17].
Phenotypic and genotypic identification of MRSA strains
For phenotypic identification of MRSA strains, sus-
ceptibility of isolates to cefoxitin (30 µg) and oxacillin 
(1  μg) disks (Mast, UK) were determined by disk dif-
fusion method according to Clinical and Laboratory 
Standards Institute (CLSI) guidelines. The S. aureus 
strain COL and S. aureus ATCC 25923 were used as 
MRSA and methicillin-susceptible Staphylococcus 
aureus (MSSA) control strains respectively.
MRSA strains which had been identified phenotypi-
cally, confirmed by amplification of mecA and femA 
genes by PCR assays using specific primers [9, 19]. 
Genomic DNA was extracted by phenol chloroform 
method. PCR of mecA gene was done to amplify a 
268  bp amplicon and reaction conditions was as fol-
lows: 6 min at 97 °C, 30 cycles of 30 s at 92 °C, 30 s at 
55 °C, 45 s at 72 °C, and finally 10 min at 72 °C [20].
Also for amplification of 450  bp amplicon of femA 
gene the following PCR program was used: 94  °C for 
5 min, 40 cycles of denaturation (94 °C, 30 s), anneal-
ing (55  °C, 40  s) and primer extension (72  °C, 50  s), 
with a final extension at 72 °C for 10 min [21].
Antibiotic susceptibility testing
According to the CLSI guidelines, resistance to antimi-
crobial agents was determined by disk diffusion method. 
The studied antibiotics were purchased from MAST 
company (Mast, UK) including: cefazolin, erythromycin, 
clindamycin, linezolid, trimethoprim sulfamethoxazole, 
vancomycin. The S. aureus strain ATCC 25923 was used 
as control. Vancomycin and oxacillin MICs of MRSA 
strains were determined using broth microdilution 
method and interpretation was done using susceptibility 
breakpoints according to the CLSI guidelines [18].
Biofilm production assays
Ability of biofilm production of all S. aureus isolates were 
determined by crystal violet staining assay [22]. As a neg-
ative control, uninoculated medium was used for deter-
mination of background OD. The average OD values were 
calculated for all tested strains and negative controls, and 
the cut-off OD value (ODc) was established. For interpre-
tation of the results, strains were divided into the follow-
ing groups: (I) OD ≤ ODc = no biofilm producer (0), (II), 
ODc < OD ≤ (2 × ODc) = weak biofilm producer (+ or 1), 
(III) (2 × ODc) < OD ≤ (4 × ODc) = moderate biofilm pro-
ducer (++ or 2), (IV) (4 × ODc) < OD = strong biofilm 
producer (+++ or 3) [23].
Detection of icaA and icaD genes
The icaA and icaD genes were amplified in MRSA 
strains by PCR to detect 814 bp and 371 bp amplicons 
respectively using primers reported in reference 24. 
DNA amplification was carried out in a thermocycler 
(Eppendorf master  cycler®, MA) with the following 
program: 94 °C, 5 min, followed by 50 cycles of (94 °C, 
30 s, 59 °C, 30 s and 72 °C, 30 s) ending with 72 °C for 
1 min [24]. After electrophoresis on 1% gel agarose the 
PCR products were visualized under UV transillumina-
tor (Bio-Rad, UK).
Molecular analysis of spa gene
The variable polymorphic X region of the spa gene was 
amplified in MRSA strains and amplification reaction 
was according to previous studies [25].
Statistical analysis
Statistical analyses were done using SPSS software ver-
sion 21 (SPSS, Inc.). Differences were considered by 
the Chi square (χ2) test and P-values less than 0.05 was 
considered statistically significant.
Results
Of the 146 S. aureus isolates 64 (43.8%) and 82 (56.2%) 
isolates were recovered from males and females, 
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respectively. The age of patients ranged from 4 months 
to 84 years with the mean age of 43.02 years. The clini-
cal specimens included burn wound 56 (38.4%), dia-
betic wound infection 5 (3.4%), traumatic wounds 6 
(4.1%), eye infection 49 (33.6%), urine 9 (6.2%), blood 3 
(2%), brain abscess 5 (3.4%), respiratory tract infections 
11 (7.5%), and other infections 2 (1.4%) (Table 1).
Among total S. aureus isolates, 24 (16.4%) identified 
as MRSA strains by disk diffusion method using cefoxi-
tin and oxacillin disks, while the remaining 122 (83.6%) 
strains were MSSA. All 24 identified MRSA strains 
showed to carry mecA and femA genes.
The results of the antimicrobial sensitivity tests are 
represented in Table  2. Vancomycin resistance was 
not detected among the S. aureus isolates, although 3 
(2.1%) of isolates showed resistance to linezolid. Also 
52 (35.6%) of isolates identified as multidrug resistant 
(MDR) strains, which most of them were isolated from 
burn wounds and eye infections, respectively (Table  2). 
The results of phenotypic study of biofilm production, 
showed that 136 of 146 (93.1%) S. aureus isolates was 
biofilm producer, from which, 111, 6 and 19 isolates iden-
tified as strong, moderate and weak biofilm producers 
respectively. Also 23/24 (95.8%) MRSA strains identified 
as biofilm producer, from which 21 (87.5%), 1 (4.2%) and 
1 (4.2%) were strong, moderate and weak biofilm pro-
ducers, respectively. The results of phenotypic study of 
biofilm production in MSSA strains were as follow: 113 
out of 122 (92.6%) MSSA isolates were biofilm producer, 
from which 90 (73.7%), 5 (4.1%) and 18 (14.8) identified 
with strong, moderate and weak biofilm production abil-
ity respectively.
Molecular study of icaA and icaD genes among 24 
MRSA strains revealed that 18 isolates carried icaA gene 
while icaD gene was not detected in all MRSA strains, 
and 6 isolates did not carry any of these two genes. Sev-
enteen out Of 18 icaA positive MRSA strains, had been 
identified as strong biofilm producers by phenotypic 
method, whilst 4/6 MRSA strains that did not carry ica 
genes, were strong biofilm producer. Analysis of spa 
gene among 24 MRSA isolates showed that 17/24 MRSA 
strains carried spa genes of different types (Table  3). 
From which 14 spa positive MRSA strains identified with 
one band of different length including 150, 270, 300, 360, 
400 bp and 3 spa positive MRSA strains founded to carry 
double bands of spa genes with the length of 150–300 bp. 
Majority of spa positive MRSA strains had one band with 
the length of 300 bp.
The statistical analyses showed significant correlation 
between MRSA isolation and MDR phenotype. Also a 
clear association was seen between the methicillin resist-
ance and hospital where the clinical specimen has been 
isolated (P ˂ 0.05).
Table 1 Comparison between  MRSA and  MSSA isolates 
regarding  characteristics of  patients, biofilm production 
ability and antibiotic resistance
a Methicillin-resistant Staphylococcus aureus
b Methicillin-susceptible Staphylococcus aureus
c P< 0.05 is significant
d Intensive care unit
e Multiple-drug resistance
Factors MRSAa, N (%) MSSAb, N (%) P-valuec
Age
 0–25 3 (12.5) 33 (27.0) 0.33
 26–50 9 (37.5) 35 (28.7)
 51–84 12 (50.0) 54 (44.3)
Sex
 Male 13 (54.2) 51 (41.8) 0.08
 Female 11 (45.8) 71 (58.2)
Clinical specimens
 Burn wound 15 (62.4) 41 (33.6) 0.12
 Diabetic wound 0 (0.0) 5 (4.1)
 Traumatic wounds 0 (0.0) 6 (4.9)
 Eye 6 (25.0) 43 (35.2)
 Urine 0 (0.0) 9 (7.4)
 Blood 1 (4.2) 2 (1.7)
 Brain abscess 1 (4.2) 4 (3.3)
 Respiratory tract 1 (4.2) 10 (8.2)
 Other – 2 (1.6)
Hospitals
 Kashan 0.001
  Shahid Beheshti 3 (12.5) 49 (40.2)
 Isfahan
  Imam Musa Kazem 
(Burns hospital)
15(62.5) 41(33.6)
  Al-Zahra 2(8.3) 29(23.7)
  Amin 4(16.7) 3(2.5)
Wards
 Burns 15(62.5) 41(33.6) 0.09
 Infectious diseases – 14(11.5)
 Emergency 7(29.2) 47(38.5)
 ICUd 2(8.3) 11(9.0)
 Outpatients – 9(7.4)
Biofilm production ability
 Strong 21 (87.5) 90 (73.7) 0.43
 Moderate 1 (4.2) 5 (4.1)
 Weak 1 (4.2) 18 (14.8)
 Non-biofilm producers 1 (4.2) 9 (7.4)
Antibiotic resistance
 MDRe 20 (83.3) 32 (26.2) 0.001
 Non-MDR 4 (16.7) 90 (73.8)
Total 24 122
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Discussion
Our data revealed that of all S. aureus isolates, 16.4% 
identified as MRSA strains by both phenotypic and gen-
otypic methods. The prevalence of MRSA strains var-
ies in different geographic regions, as in a review study 
has been shown that the prevalence of MRSA infection 
ranges from 13 to 74.0% in different parts of the world 
[26]. In Iran, a meta-analysis study has been reported 
that prevalence of MRSA infections in Mazandaran, Isfa-
han, Markazi, Golestan and Kerman Provinces is about 
Table 2 The antimicrobial sensitivity tests of MSSA and MRSA isolates by disk diffusion method
Antibiotic MSSA (n = 122) MRSA (n = 24)
Susceptible N (%) Intermediate N (%) Resistant N (%) Susceptible N (%) Intermediate 
N (%)
Resistant N (%)
Erythromycin 62 (50.8) 32 (26.2) 28 (23.0) 5 (20.8) 2 (8.4) 17 (70.8)
Clindamycin 100 (82.0) 14 (11.5) 8 (6.5) 6 (25.0) 4 (16.7) 14 (58.3)
Cefoxitin 122 (83.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 24 (16.4)
Cefazolin 119 (97.5) 2 (1.7) 1 (0.8) 11 (45.8) 0 (0.0) 13 (54.2)
Linezolid 120 (98.4) 0 (0.0) 2 (1.6) 23 (95.8) 0 (0.0) 1 (4.2)
Trimethoprim/sul-
famethoxazole
112 (91.8) 4 (3.3) 6 (4.9) 16 (66.7) 0 (0.0) 8 (33.3)
Table 3 Analysis of spa gene in MRSA isolates regarding to hospital and clinical specimens
a Imam Musa Kazem Burns hospital
spa band Size (bp) Number (%) Sex Clinical specimens Hospital Wards
No band
– 7 (29.1) Male Burn wound IMKa Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Female Eye Amin Emergency
Female Eye Amin Emergency
Female Eye Amin Emergency
Female Brain abscess Al-Zahra ICU
One band
150 3 (12.5) Male Burn wound IMK Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Female Burn wound IMK Burns hospital Burns
270 4 (16.7) Male Burn wound IMK Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Female Eye Amin Emergency
300 4 (16.7) Male Blood Shahid Beheshti Emergency
Male Eye Shahid Beheshti Emergency
Male Burn wound IMK Burns hospital Burns
Female Respiratory tract Al-Zahra ICU
360 2 (8.3) Female Eye Shahid Beheshti Emergency
Female Burn wound IMK Burns hospital Burns
400 − 4.2 Female Burn wound IMK Burns hospital Burns
Two band
150–300 3 (12.5) Male Burn wound IMK Burns hospital Burns
Male Burn wound IMK Burns hospital Burns
Female Burn wound IMK Burns hospital Burns
Total 24 (100)
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20.5 percent [27, 28]. Despite there was no significant 
relationship between sex, clinical specimens and resist-
ance to methicillin (P > 0.05), most MRSA isolates were 
recovered from men over 50 years old with burn wound 
infections. These results may be due to the fact that men 
are more likely to be burned because of their jobs; also 
antibiotic resistance is high in the bacterial strains that 
cause burn infections. Linezolid is a new class of antibi-
otics that are introduced for treatment of infections due 
to MRSA [29]. Linezolid-resistant Staphylococcus aureus 
(LRSA) is still very uncommon [30]. In the present study 
we have reported the emergence of LRSA strains in our 
region for the first time. The published reports of infec-
tions due to LRSA strains between the years 2001 and 
2011 in different parts of world indicate a prevalence 
of 0.05% [31]. In studies conducted in different geo-
graphic areas of Iran, the LRSA strains have not been 
documented, except studies conducted in Tabriz and 
Mashhad [32]. Isolation of LRSA strains from important 
clinical specimens such as burn wound infection and dia-
betic foot ulcer, can be a serious threat due to the spread 
of these resistant strains in the hospitals. Detailed studies 
based on molecular typing of strains can be very benefi-
cial in this field. The ability of S. aureus strains to produce 
biofilm due to the durability and antibiotic resistance is 
among the most important virulence factors [33]. Major-
ity of our studied S. aureus strains had the ability to pro-
duce strong biofilm. In comparison to other studies in 
Iran, the ability and power of biofilm production in our 
strains was much higher; however, the methods used in 
studies also contribute to this difference [34, 35]. Since 
the most of our S. aureus strains have been isolated from 
hospitalized patients and clinical samples such as burn 
wounds, this high power of biofilm production is very 
important and requires more detailed studies in this 
regard. Although different genes are involved in biofilm 
production, but in contradiction to other studies, icaD 
gene was not detected in our biofilm producer MRSA 
strains and icaA gene was the gene specifically detected 
in our MRSA strains with the ability of strong biofilm 
production [36]. The interesting result in this context was 
that 4/6 MRSA strains that did not carry ica genes, were 
strong biofilm producers. This indicates that genes other 
than ica may have been involved in biofilm formation in 
these strains.
The analysis of spa genes showed that the length of 
detected genes in the present study was shorter than 
the length of the spa genes identified by Shakeri et al. in 
north of Iran [37]. This can be related to the differences 
in the pattern of distribution of spa types across different 
geographic regions. Using the sequencing method and 
determining the exact spa types of S. aureus strains can 
be helpful in proving this claim. In the current study, 6 
different patterns of spa gene are detected. Findings of an 
investigation have been reported 5 different patterns of 
this gene among patients with staphylococcal infections 
[10].
Conclusion
According to data obtained, the prevalence of MRSA 
strains in S. aureus isolates from Isfahan Province Hos-
pitals is relatively high and a remarkable percentage of 
them show strong power in biofilm production. Also 
analysis of spa gene showed a fairly large diversity among 
MRSA strains isolated from different hospitals, although 
more detailed studies using sequencing and accurate typ-
ing methods such as MLST can prove this claim.
Limitations
• The most important limitation of the present study 
is that the molecular study of genes involved in bio-
film production has been performed only in MRSA 
strains and the mentioned studies have not been per-
formed on MSSA strains.
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